ArticleEuropean heart journal. Case reports2022

Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy.

Aldostefano Porcari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.